Search research articles
Contact Us
Filters
Showing results (81-90 of 103) with videos related to
Page
of 11
Sort By:
Internal Medicine (Tokyo, Japan)
|
August 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
Makoto Murata, Ritsuro Suzuki, Tetsuya Nishida, et al.
Science Immunology
|
October 7, 2022
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors
Kota Itahashi, Takuma Irie, Junichiro Yuda, et al.
Hematological Oncology
|
April 8, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation
Yutaka Shimazu, Makoto Murata, Takeshi Kondo, et al.
Cancer Medicine
|
October 6, 2020
Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma
Takafumi Shichijo, Dai Maruyama, Nobuhiko Yamauchi, et al.
Blood Advances
|
June 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML
Naoto Takahashi, Yosuke Minami, Yuki Fujioka, et al.
Blood Advances
|
June 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs
Takaaki Ono, Takashi Okada, Naoto Takahashi, et al.
International Journal of Hematology
|
September 11, 2016
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen
Yoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, et al.
Blood Advances
|
July 5, 2024
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta, et al.
Blood Neoplasia
|
June 8, 2026
Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan
Minoru Kanaya, Yuji Mukai, Goichi Yoshimoto, et al.
JAMA
|
May 9, 2024
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Elias Jabbour, Hagop M Kantarjian, Ibrahim Aldoss, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 103) with videos related to
Sort By:
Page
of 11
Internal Medicine (Tokyo, Japan)
|
August 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation for Post-essential Thrombocythemia and Post-polycythemia Vera Myelofibrosis
Makoto Murata, Ritsuro Suzuki, Tetsuya Nishida, et al.
Science Immunology
|
October 7, 2022
BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors
Kota Itahashi, Takuma Irie, Junichiro Yuda, et al.
Hematological Oncology
|
April 8, 2022
The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation
Yutaka Shimazu, Makoto Murata, Takeshi Kondo, et al.
Cancer Medicine
|
October 6, 2020
Transformation Scoring System (TSS): A new assessment index for clinical transformation of follicular lymphoma
Takafumi Shichijo, Dai Maruyama, Nobuhiko Yamauchi, et al.
Blood Advances
|
June 18, 2026
Treatment-Free Remission and Immune Profiling after Frontline Second-Generation TKI Therapy in CML
Naoto Takahashi, Yosuke Minami, Yuki Fujioka, et al.
Blood Advances
|
June 11, 2026
Early predictors of MR4.5 attainment and eligibility for TKI discontinuation in CML treated with second-generation TKIs
Takaaki Ono, Takashi Okada, Naoto Takahashi, et al.
International Journal of Hematology
|
September 11, 2016
A prospective study of the antiemetic effect of palonosetron in malignant lymphoma patients treated with the CHOP regimen
Yoshiharu Miyata, Kimikazu Yakushijin, Yumiko Inui, et al.
Blood Advances
|
July 5, 2024
Nilotinib vs dasatinib in achieving MR4.5 for de novo chronic myeloid leukemia: the randomized JALSG CML212 study
Itaru Matsumura, Shigeki Ohtake, Yoshiko Atsuta, et al.
Blood Neoplasia
|
June 8, 2026
Real-world pharmacokinetics of venetoclax in patients with acute myeloid leukemia in Japan
Minoru Kanaya, Yuji Mukai, Goichi Yoshimoto, et al.
JAMA
|
May 9, 2024
Ponatinib vs Imatinib in Frontline Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial
Elias Jabbour, Hagop M Kantarjian, Ibrahim Aldoss, et al.
Page
of 11